Search research articles
Contact Us
Filters
Showing results (111-120 of 158) with videos related to
Page
of 16
Sort By:
Biorxiv : the Preprint Server for Biology
|
February 24, 2025
Single Cell Resolution Tracking of Cutaneous T-Cell Lymphoma Reveals Clonal Evolution in Disease Progression
Hannah K Dorando, Jared M Andrews, Nicholas C Borcherding, et al.
Blood Advances
|
October 1, 2020
T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphoma
Paola Ghione, Promie Faruque, Neha Mehta-Shah, et al.
Haematologica
|
September 14, 2023
A phase II study of interrupted and continuous dose lenalidomide in relapsed/refractory Hodgkin lymphoma
Todd A Fehniger, Marcus P Watkins, Nkiruka Ezenwajiaku, et al.
Cancers
|
June 24, 2022
Metabolic Biomarkers Assessed with PET/CT Predict Sex-Specific Longitudinal Outcomes in Patients with Diffuse Large B-Cell Lymphoma
Shama Jaswal, Vanessa Sanders, Priyanka Pullarkat, et al.
Blood
|
June 28, 2019
Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark
Justin Taylor, Michael Haddadin, Vivek A Upadhyay, et al.
The ISME Journal
|
January 8, 2025
Magnetotactic bacteria affiliated with diverse Pseudomonadota families biomineralize intracellular Ca-carbonate
Camille C Mangin, Karim Benzerara, Marine Bergot, et al.
Blood Advances
|
March 26, 2024
Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma
Pier Luigi Zinzani, Gilles Salles, Alison J Moskowitz, et al.
Blood
|
February 9, 2026
Multi-omic Study of Cutaneous T-Cell Lymphoma Reveals Single Cell Clonal Evolution in Progression and Therapy Resistance
Hannah K Dorando, Jared M Andrews, Oam U Khatavkar, et al.
Blood Advances
|
March 4, 2020
Rituximab/bendamustine and rituximab/cytarabine induction therapy for transplant-eligible mantle cell lymphoma
Reid W Merryman, Natasha Edwin, Robert Redd, et al.
Blood
|
February 16, 2023
Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL
Jia Ruan, Alison Moskowitz, Neha Mehta-Shah, et al.
Page
of 16
Search research articles
Search
Showing results (111-120 of 158) with videos related to
Sort By:
Page
of 16
Biorxiv : the Preprint Server for Biology
|
February 24, 2025
Single Cell Resolution Tracking of Cutaneous T-Cell Lymphoma Reveals Clonal Evolution in Disease Progression
Hannah K Dorando, Jared M Andrews, Nicholas C Borcherding, et al.
Blood Advances
|
October 1, 2020
T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphoma
Paola Ghione, Promie Faruque, Neha Mehta-Shah, et al.
Haematologica
|
September 14, 2023
A phase II study of interrupted and continuous dose lenalidomide in relapsed/refractory Hodgkin lymphoma
Todd A Fehniger, Marcus P Watkins, Nkiruka Ezenwajiaku, et al.
Cancers
|
June 24, 2022
Metabolic Biomarkers Assessed with PET/CT Predict Sex-Specific Longitudinal Outcomes in Patients with Diffuse Large B-Cell Lymphoma
Shama Jaswal, Vanessa Sanders, Priyanka Pullarkat, et al.
Blood
|
June 28, 2019
Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark
Justin Taylor, Michael Haddadin, Vivek A Upadhyay, et al.
The ISME Journal
|
January 8, 2025
Magnetotactic bacteria affiliated with diverse Pseudomonadota families biomineralize intracellular Ca-carbonate
Camille C Mangin, Karim Benzerara, Marine Bergot, et al.
Blood Advances
|
March 26, 2024
Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma
Pier Luigi Zinzani, Gilles Salles, Alison J Moskowitz, et al.
Blood
|
February 9, 2026
Multi-omic Study of Cutaneous T-Cell Lymphoma Reveals Single Cell Clonal Evolution in Progression and Therapy Resistance
Hannah K Dorando, Jared M Andrews, Oam U Khatavkar, et al.
Blood Advances
|
March 4, 2020
Rituximab/bendamustine and rituximab/cytarabine induction therapy for transplant-eligible mantle cell lymphoma
Reid W Merryman, Natasha Edwin, Robert Redd, et al.
Blood
|
February 16, 2023
Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL
Jia Ruan, Alison Moskowitz, Neha Mehta-Shah, et al.
Page
of 16